ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Estrogen and Progestin Extended-Release Patches Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35R14381
Home | Market Reports | Health| Reproductive Health
Global Estrogen and Progestin Extended Release Patches Market Research Report 2023
BUY CHAPTERS

Global Estrogen and Progestin Extended-Release Patches Market Research Report 2025

Code: QYRE-Auto-35R14381
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mylan Pharmaceuticals Inc.(Viatris)
Twirla
Novartis(Hexal AG)
Bayer HealthCare Pharmaceuticals
Noven
AbbVie
Hisamitsu Pharmaceutical Co Inc
WATSON Pharmaceuticals
Johnson & Johnson
ANI Pharmaceuticals
Zhejiang Yatai Pharmaceutical Company Ltd.

Estrogen and Progestin Extended-Release Patches Market

The global market for Estrogen and Progestin Extended-Release Patches was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Estrogen and Progestin Extended-Release Patches is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Estrogen and Progestin Extended-Release Patches is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Estrogen and Progestin Extended-Release Patches include Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals, Johnson & Johnson, ANI Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Estrogen and Progestin Extended-Release Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progestin Extended-Release Patches.
The Estrogen and Progestin Extended-Release Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Estrogen and Progestin Extended-Release Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Estrogen and Progestin Extended-Release Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Estrogen and Progestin Extended-Release Patches Market Report

Report Metric Details
Report Name Estrogen and Progestin Extended-Release Patches Market
Segment by Type
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals, Johnson & Johnson, ANI Pharmaceuticals, Zhejiang Yatai Pharmaceutical Company Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Estrogen and Progestin Extended-Release Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Estrogen and Progestin Extended-Release Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Estrogen and Progestin Extended-Release Patches Market report?

Ans: The main players in the Estrogen and Progestin Extended-Release Patches Market are Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals, Johnson & Johnson, ANI Pharmaceuticals, Zhejiang Yatai Pharmaceutical Company Ltd.

What are the Application segmentation covered in the Estrogen and Progestin Extended-Release Patches Market report?

Ans: The Applications covered in the Estrogen and Progestin Extended-Release Patches Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Estrogen and Progestin Extended-Release Patches Market report?

Ans: The Types covered in the Estrogen and Progestin Extended-Release Patches Market report are Contraceptive Patch, Estradiol Patch, Others

Recommended Reports

Women's Health Patches

Hormonal Therapy Markets

Contraceptive Products

1 Estrogen and Progestin Extended-Release Patches Market Overview
1.1 Product Definition
1.2 Estrogen and Progestin Extended-Release Patches by Type
1.2.1 Global Estrogen and Progestin Extended-Release Patches Market Value Comparison by Type (2024 VS 2031)
1.2.2 Contraceptive Patch
1.2.3 Estradiol Patch
1.2.4 Others
1.3 Estrogen and Progestin Extended-Release Patches by Application
1.3.1 Global Estrogen and Progestin Extended-Release Patches Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Estrogen and Progestin Extended-Release Patches Market Size Estimates and Forecasts
1.4.1 Global Estrogen and Progestin Extended-Release Patches Revenue 2020-2031
1.4.2 Global Estrogen and Progestin Extended-Release Patches Sales 2020-2031
1.4.3 Global Estrogen and Progestin Extended-Release Patches Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Estrogen and Progestin Extended-Release Patches Market Competition by Manufacturers
2.1 Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Manufacturers (2020-2025)
2.2 Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Estrogen and Progestin Extended-Release Patches Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Estrogen and Progestin Extended-Release Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Estrogen and Progestin Extended-Release Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Estrogen and Progestin Extended-Release Patches, Product Type & Application
2.7 Global Key Manufacturers of Estrogen and Progestin Extended-Release Patches, Date of Enter into This Industry
2.8 Global Estrogen and Progestin Extended-Release Patches Market Competitive Situation and Trends
2.8.1 Global Estrogen and Progestin Extended-Release Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Estrogen and Progestin Extended-Release Patches Players Market Share by Revenue
2.8.3 Global Estrogen and Progestin Extended-Release Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Estrogen and Progestin Extended-Release Patches Market Scenario by Region
3.1 Global Estrogen and Progestin Extended-Release Patches Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Estrogen and Progestin Extended-Release Patches Sales by Region: 2020-2031
3.2.1 Global Estrogen and Progestin Extended-Release Patches Sales by Region: 2020-2025
3.2.2 Global Estrogen and Progestin Extended-Release Patches Sales by Region: 2026-2031
3.3 Global Estrogen and Progestin Extended-Release Patches Revenue by Region: 2020-2031
3.3.1 Global Estrogen and Progestin Extended-Release Patches Revenue by Region: 2020-2025
3.3.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Region: 2026-2031
3.4 North America Estrogen and Progestin Extended-Release Patches Market Facts & Figures by Country
3.4.1 North America Estrogen and Progestin Extended-Release Patches Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2031)
3.4.3 North America Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Estrogen and Progestin Extended-Release Patches Market Facts & Figures by Country
3.5.1 Europe Estrogen and Progestin Extended-Release Patches Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2031)
3.5.3 Europe Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Estrogen and Progestin Extended-Release Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Estrogen and Progestin Extended-Release Patches Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Estrogen and Progestin Extended-Release Patches Sales by Region (2020-2031)
3.6.3 Asia Pacific Estrogen and Progestin Extended-Release Patches Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Estrogen and Progestin Extended-Release Patches Market Facts & Figures by Country
3.7.1 Latin America Estrogen and Progestin Extended-Release Patches Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2031)
3.7.3 Latin America Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Estrogen and Progestin Extended-Release Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Estrogen and Progestin Extended-Release Patches Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2031)
3.8.3 Middle East and Africa Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Estrogen and Progestin Extended-Release Patches Sales by Type (2020-2031)
4.1.1 Global Estrogen and Progestin Extended-Release Patches Sales by Type (2020-2025)
4.1.2 Global Estrogen and Progestin Extended-Release Patches Sales by Type (2026-2031)
4.1.3 Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Type (2020-2031)
4.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Type (2020-2031)
4.2.1 Global Estrogen and Progestin Extended-Release Patches Revenue by Type (2020-2025)
4.2.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Type (2026-2031)
4.2.3 Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Type (2020-2031)
4.3 Global Estrogen and Progestin Extended-Release Patches Price by Type (2020-2031)
5 Segment by Application
5.1 Global Estrogen and Progestin Extended-Release Patches Sales by Application (2020-2031)
5.1.1 Global Estrogen and Progestin Extended-Release Patches Sales by Application (2020-2025)
5.1.2 Global Estrogen and Progestin Extended-Release Patches Sales by Application (2026-2031)
5.1.3 Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Application (2020-2031)
5.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Application (2020-2031)
5.2.1 Global Estrogen and Progestin Extended-Release Patches Revenue by Application (2020-2025)
5.2.2 Global Estrogen and Progestin Extended-Release Patches Revenue by Application (2026-2031)
5.2.3 Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Application (2020-2031)
5.3 Global Estrogen and Progestin Extended-Release Patches Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mylan Pharmaceuticals Inc.(Viatris)
6.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Information
6.1.2 Mylan Pharmaceuticals Inc.(Viatris) Description and Business Overview
6.1.3 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Product Portfolio
6.1.5 Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
6.2 Twirla
6.2.1 Twirla Company Information
6.2.2 Twirla Description and Business Overview
6.2.3 Twirla Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Twirla Estrogen and Progestin Extended-Release Patches Product Portfolio
6.2.5 Twirla Recent Developments/Updates
6.3 Novartis(HEXAL AG)
6.3.1 Novartis(HEXAL AG) Company Information
6.3.2 Novartis(HEXAL AG) Description and Business Overview
6.3.3 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Product Portfolio
6.3.5 Novartis(HEXAL AG) Recent Developments/Updates
6.4 Bayer Healthcare Pharmaceuticals
6.4.1 Bayer Healthcare Pharmaceuticals Company Information
6.4.2 Bayer Healthcare Pharmaceuticals Description and Business Overview
6.4.3 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product Portfolio
6.4.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
6.5 Noven
6.5.1 Noven Company Information
6.5.2 Noven Description and Business Overview
6.5.3 Noven Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Noven Estrogen and Progestin Extended-Release Patches Product Portfolio
6.5.5 Noven Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Company Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie Estrogen and Progestin Extended-Release Patches Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Hisamitsu Pharmaceutical Co., Inc.
6.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
6.7.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.7.3 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Product Portfolio
6.7.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.8 Watson Pharmaceuticals
6.8.1 Watson Pharmaceuticals Company Information
6.8.2 Watson Pharmaceuticals Description and Business Overview
6.8.3 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product Portfolio
6.8.5 Watson Pharmaceuticals Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 ANI Pharmaceuticals
6.10.1 ANI Pharmaceuticals Company Information
6.10.2 ANI Pharmaceuticals Description and Business Overview
6.10.3 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product Portfolio
6.10.5 ANI Pharmaceuticals Recent Developments/Updates
6.11 Zhejiang Yatai Pharmaceutical Company Ltd.
6.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
6.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Description and Business Overview
6.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Product Portfolio
6.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Estrogen and Progestin Extended-Release Patches Industry Chain Analysis
7.2 Estrogen and Progestin Extended-Release Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Estrogen and Progestin Extended-Release Patches Production Mode & Process Analysis
7.4 Estrogen and Progestin Extended-Release Patches Sales and Marketing
7.4.1 Estrogen and Progestin Extended-Release Patches Sales Channels
7.4.2 Estrogen and Progestin Extended-Release Patches Distributors
7.5 Estrogen and Progestin Extended-Release Patches Customer Analysis
8 Estrogen and Progestin Extended-Release Patches Market Dynamics
8.1 Estrogen and Progestin Extended-Release Patches Industry Trends
8.2 Estrogen and Progestin Extended-Release Patches Market Drivers
8.3 Estrogen and Progestin Extended-Release Patches Market Challenges
8.4 Estrogen and Progestin Extended-Release Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mylan Pharmaceuticals Inc.(Viatris)
Twirla
Novartis(Hexal AG)
Bayer HealthCare Pharmaceuticals
Noven
AbbVie
Hisamitsu Pharmaceutical Co Inc
WATSON Pharmaceuticals
Johnson & Johnson
ANI Pharmaceuticals
Zhejiang Yatai Pharmaceutical Company Ltd.
List of Tables
 Table 1. Global Estrogen and Progestin Extended-Release Patches Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Estrogen and Progestin Extended-Release Patches Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Estrogen and Progestin Extended-Release Patches Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Estrogen and Progestin Extended-Release Patches Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Estrogen and Progestin Extended-Release Patches Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Estrogen and Progestin Extended-Release Patches Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Estrogen and Progestin Extended-Release Patches Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Estrogen and Progestin Extended-Release Patches, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Estrogen and Progestin Extended-Release Patches, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Estrogen and Progestin Extended-Release Patches, Product Type & Application
 Table 12. Global Key Manufacturers of Estrogen and Progestin Extended-Release Patches, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Estrogen and Progestin Extended-Release Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen and Progestin Extended-Release Patches as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Estrogen and Progestin Extended-Release Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Estrogen and Progestin Extended-Release Patches Sales by Region (2020-2025) & (K Units)
 Table 18. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Region (2020-2025)
 Table 19. Global Estrogen and Progestin Extended-Release Patches Sales by Region (2026-2031) & (K Units)
 Table 20. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Region (2026-2031)
 Table 21. Global Estrogen and Progestin Extended-Release Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Region (2020-2025)
 Table 23. Global Estrogen and Progestin Extended-Release Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Region (2026-2031)
 Table 25. North America Estrogen and Progestin Extended-Release Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2025) & (K Units)
 Table 27. North America Estrogen and Progestin Extended-Release Patches Sales by Country (2026-2031) & (K Units)
 Table 28. North America Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Estrogen and Progestin Extended-Release Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Estrogen and Progestin Extended-Release Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Estrogen and Progestin Extended-Release Patches Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Estrogen and Progestin Extended-Release Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Estrogen and Progestin Extended-Release Patches Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Estrogen and Progestin Extended-Release Patches Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Estrogen and Progestin Extended-Release Patches Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Estrogen and Progestin Extended-Release Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Estrogen and Progestin Extended-Release Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Estrogen and Progestin Extended-Release Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Estrogen and Progestin Extended-Release Patches Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Estrogen and Progestin Extended-Release Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Estrogen and Progestin Extended-Release Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Estrogen and Progestin Extended-Release Patches Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Estrogen and Progestin Extended-Release Patches Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Estrogen and Progestin Extended-Release Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Estrogen and Progestin Extended-Release Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Estrogen and Progestin Extended-Release Patches Sales (K Units) by Type (2020-2025)
 Table 51. Global Estrogen and Progestin Extended-Release Patches Sales (K Units) by Type (2026-2031)
 Table 52. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Type (2020-2025)
 Table 53. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Type (2026-2031)
 Table 54. Global Estrogen and Progestin Extended-Release Patches Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Estrogen and Progestin Extended-Release Patches Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Type (2020-2025)
 Table 57. Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Type (2026-2031)
 Table 58. Global Estrogen and Progestin Extended-Release Patches Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Estrogen and Progestin Extended-Release Patches Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Estrogen and Progestin Extended-Release Patches Sales (K Units) by Application (2020-2025)
 Table 61. Global Estrogen and Progestin Extended-Release Patches Sales (K Units) by Application (2026-2031)
 Table 62. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Application (2020-2025)
 Table 63. Global Estrogen and Progestin Extended-Release Patches Sales Market Share by Application (2026-2031)
 Table 64. Global Estrogen and Progestin Extended-Release Patches Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Estrogen and Progestin Extended-Release Patches Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Application (2020-2025)
 Table 67. Global Estrogen and Progestin Extended-Release Patches Revenue Market Share by Application (2026-2031)
 Table 68. Global Estrogen and Progestin Extended-Release Patches Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Estrogen and Progestin Extended-Release Patches Price (US$/Unit) by Application (2026-2031)
 Table 70. Mylan Pharmaceuticals Inc.(Viatris) Company Information
 Table 71. Mylan Pharmaceuticals Inc.(Viatris) Description and Business Overview
 Table 72. Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Product
 Table 74. Mylan Pharmaceuticals Inc.(Viatris) Recent Developments/Updates
 Table 75. Twirla Company Information
 Table 76. Twirla Description and Business Overview
 Table 77. Twirla Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Twirla Estrogen and Progestin Extended-Release Patches Product
 Table 79. Twirla Recent Developments/Updates
 Table 80. Novartis(HEXAL AG) Company Information
 Table 81. Novartis(HEXAL AG) Description and Business Overview
 Table 82. Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Product
 Table 84. Novartis(HEXAL AG) Recent Developments/Updates
 Table 85. Bayer Healthcare Pharmaceuticals Company Information
 Table 86. Bayer Healthcare Pharmaceuticals Description and Business Overview
 Table 87. Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product
 Table 89. Bayer Healthcare Pharmaceuticals Recent Developments/Updates
 Table 90. Noven Company Information
 Table 91. Noven Description and Business Overview
 Table 92. Noven Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Noven Estrogen and Progestin Extended-Release Patches Product
 Table 94. Noven Recent Developments/Updates
 Table 95. AbbVie Company Information
 Table 96. AbbVie Description and Business Overview
 Table 97. AbbVie Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AbbVie Estrogen and Progestin Extended-Release Patches Product
 Table 99. AbbVie Recent Developments/Updates
 Table 100. Hisamitsu Pharmaceutical Co., Inc. Company Information
 Table 101. Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
 Table 102. Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Product
 Table 104. Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
 Table 105. Watson Pharmaceuticals Company Information
 Table 106. Watson Pharmaceuticals Description and Business Overview
 Table 107. Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product
 Table 109. Watson Pharmaceuticals Recent Developments/Updates
 Table 110. Johnson & Johnson Company Information
 Table 111. Johnson & Johnson Description and Business Overview
 Table 112. Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Johnson & Johnson Estrogen and Progestin Extended-Release Patches Product
 Table 114. Johnson & Johnson Recent Developments/Updates
 Table 115. ANI Pharmaceuticals Company Information
 Table 116. ANI Pharmaceuticals Description and Business Overview
 Table 117. ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Product
 Table 119. ANI Pharmaceuticals Recent Developments/Updates
 Table 120. Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
 Table 121. Zhejiang Yatai Pharmaceutical Company Ltd. Description and Business Overview
 Table 122. Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Product
 Table 124. Zhejiang Yatai Pharmaceutical Company Ltd. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Estrogen and Progestin Extended-Release Patches Distributors List
 Table 128. Estrogen and Progestin Extended-Release Patches Customers List
 Table 129. Estrogen and Progestin Extended-Release Patches Market Trends
 Table 130. Estrogen and Progestin Extended-Release Patches Market Drivers
 Table 131. Estrogen and Progestin Extended-Release Patches Market Challenges
 Table 132. Estrogen and Progestin Extended-Release Patches Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Estrogen and Progestin Extended-Release Patches
 Figure 2. Global Estrogen and Progestin Extended-Release Patches Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Estrogen and Progestin Extended-Release Patches Market Share by Type: 2024 & 2031
 Figure 4. Contraceptive Patch Product Picture
 Figure 5. Estradiol Patch Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Estrogen and Progestin Extended-Release Patches Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Estrogen and Progestin Extended-Release Patches Market Share by Application: 2024 & 2031
 Figure 9. Online Sales
 Figure 10. Offline Sales
 Figure 11. Global Estrogen and Progestin Extended-Release Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Estrogen and Progestin Extended-Release Patches Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Estrogen and Progestin Extended-Release Patches Sales (2020-2031) & (K Units)
 Figure 14. Global Estrogen and Progestin Extended-Release Patches Average Price (US$/Unit) & (2020-2031)
 Figure 15. Estrogen and Progestin Extended-Release Patches Report Years Considered
 Figure 16. Estrogen and Progestin Extended-Release Patches Sales Share by Manufacturers in 2024
 Figure 17. Global Estrogen and Progestin Extended-Release Patches Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Estrogen and Progestin Extended-Release Patches Players: Market Share by Revenue in Estrogen and Progestin Extended-Release Patches in 2024
 Figure 19. Estrogen and Progestin Extended-Release Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Estrogen and Progestin Extended-Release Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Estrogen and Progestin Extended-Release Patches Sales Market Share by Country (2020-2031)
 Figure 22. North America Estrogen and Progestin Extended-Release Patches Revenue Market Share by Country (2020-2031)
 Figure 23. United States Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Estrogen and Progestin Extended-Release Patches Sales Market Share by Country (2020-2031)
 Figure 26. Europe Estrogen and Progestin Extended-Release Patches Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Estrogen and Progestin Extended-Release Patches Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Estrogen and Progestin Extended-Release Patches Revenue Market Share by Region (2020-2031)
 Figure 34. China Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Estrogen and Progestin Extended-Release Patches Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Estrogen and Progestin Extended-Release Patches Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Estrogen and Progestin Extended-Release Patches Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Estrogen and Progestin Extended-Release Patches Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Estrogen and Progestin Extended-Release Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Estrogen and Progestin Extended-Release Patches by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Estrogen and Progestin Extended-Release Patches by Type (2020-2031)
 Figure 53. Global Estrogen and Progestin Extended-Release Patches Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Estrogen and Progestin Extended-Release Patches by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Estrogen and Progestin Extended-Release Patches by Application (2020-2031)
 Figure 56. Global Estrogen and Progestin Extended-Release Patches Price (US$/Unit) by Application (2020-2031)
 Figure 57. Estrogen and Progestin Extended-Release Patches Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Birth Control Patch Market Research Report 2025
Global Hormone Patch Market Research Report 2024
Global Topical Contraceptive Patch Market Research Report 2024
Global Contraceptive Transdermal Patche Market Research Report 2024
Global Estrogen Blocker Market Research Report 2025
Global Extracellular Matrix Patch Market Research Report 2025
Global Acne Patches Market Research Report 2025
Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Estrogen Receptor Market Research Report 2024
Global Hernia Patch Market Research Report 2025
Global Estrogen and Progesterone API Market Research Report 2024
Global Women Health Belly Patch Market Research Report 2024
Global Wearable Patches Market Research Report 2025
Global Estradiol Valerate Market Research Report 2025
Anti Acne Dermal Patch Market
Global Wellness Patch Market Research Report 2024
Global Pain Patches Market Research Report 2024
Global Acne Pimple Patches Market Research Report 2025
Global Desogestrel and Ethinyl Estradiol Tablets Market Research Report 2025
Global Pimple Patches Market Research Report 2025

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions